As the COVID-19 Delta variant spreads rapidly across certain states, the government is urging people who have not yet done so to get vaccinated. But as COVID-19 cases continue to soar and vaccinations increase, Pfizer (PFE) and AstraZeneca (NASDAQ:AZN) are seeing a significant surge in demand for their vaccines. So, we think it could be wise to bet on these stocks. Read on.Amid rising COVID-19 cases due to the virus’ highly contagious Delta variant, the government has been urging citizens to get vaccinated. In addition, because the seven-day average of COVID cases has surpassed the peak seen last summer, some states and local administrations are offering incentives to encourage people to get vaccinated pronto.
According to reports, most unvaccinated people have lately been contracting severe COVID-19 infections. Due to the concerns surrounding the new strain, the COVID-19 vaccination rate in the U.S. has risen by 26% versus three weeks ago. As such, COVID-19 vaccine manufacturers are all set to cash in on the opportunity with inoculation kicking into high gear in the coming months.
Pfizer Inc. (NYSE:PFE) and AstraZeneca Plc (AZN), which are among the few major companies currently offering COVID-19 vaccines, are expected to deliver excellent returns this year and beyond as demand for vaccines continues to soar.